?:authorAffiliation
|
-
[\'Si-M/\'Der Simulierte Mensch\', Technische Universität Berlin and Charité-Universitätsmedizin Berlin, Berlin, Germany.\', \'Regenerative Immunology and Aging, BIH Center for Regenerative Therapies, Charité-Universitätsmedizin Berlin, Berlin, Germany.\', \'Department of Hematology, Oncology and Tumor Immunology, Charité-Universitätsmedizin Berlin, Berlin, Germany.\', \'Berlin Institute of Health (BIH), Berlin, Germany.\', \'Department of Infectious Diseases and Respiratory Medicine, Charité-Universitätsmedizin Berlin, Berlin, Germany.\', \'Department of Tropical Medicine, Bernhard Nocht Institute for Tropical Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.\', \'I. Department of Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.\', \'Medical Biotechnology, Institute for Biotechnology, Technische Universität Berlin, Berlin, Germany.\', \'Department of Pediatric Pulmonology, Immunology and Critical Care Medicine, Charité-Universitätsmedizin Berlin, Berlin, Germany.\', \'Department of Infectious Diseases, Robert Koch Institut, Berlin, Germany.\', \'Miltenyi Biotec, Bergisch Gladbach, Germany.\', \'Interdisciplinary Metabolism Center, Biology of Aging (BoA) group, Charité-Universitätsmedizin Berlin, Berlin, Germany.\', \'Institute of Virology, Charité-Universitätsmedizin Berlin, Berlin, Germany.\', \'Department of Clinical and Experimental Medicine, Brighton and Sussex Medical School, Brighton, UK.\', \'JPT Peptide Technologies, Berlin, Germany.\', \'Max Planck Institute for Molecular Genetics, Berlin, Germany. giesecke@molgen.mpg.de.\', \'Berlin Institute of Health (BIH), Berlin, Germany. leif-erik.sander@charite.de.\', \'Si-M/\'Der Simulierte Mensch\', Technische Universität Berlin and Charité-Universitätsmedizin Berlin, Berlin, Germany. andreas.thiel@charite.de.\', \'Regenerative Immunology and Aging, BIH Center for Regenerative Therapies, Charité-Universitätsmedizin Berlin, Berlin, Germany. andreas.thiel@charite.de.\']
|